ClouDr Group Limited (HK:9955)
:9955
Want to see HK:9955 full AI Analyst Report?
9955 Stock Chart & Stats
HK$1.00
HK$0.03(2.52%)
At close: 4:00 PM EST
HK$1.00
HK$0.03(2.52%)
Day’s Range― - ―
52-Week RangeHK$0.52 - HK$1.80
Previous CloseN/A
Volume146.50K
Average Volume (3M)1.09M
Market Cap
HK$437.54M
Enterprise ValueHK$563.94M
Total Cash (Recent Filing)HK$445.29M
Total Debt (Recent Filing)HK$558.23M
Price to Earnings (P/E)―
Beta2.02
Next Earnings
Aug 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.60
Shares Outstanding645,718,800
10 Day Avg. Volume899,970
30 Day Avg. Volume1,090,236
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.00
Price to Sales (P/S)0.34
P/FCF Ratio-8.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.11
Revenue Forecast (FY)HK$7.73B
Bulls Say, Bears Say
Bulls Say
Omnichannel Retail FootprintClouDr's combined offline and online pharmacy network provides durable distribution breadth and customer access across channels. That multichannel presence supports steady prescription flow, cross-selling and resilience to single-channel disruption, helping sustain revenues and unit economics over months.
Material Gross Margin ImprovementA near-term jump in gross margin to ~48% suggests improved procurement, pricing or product mix that can support long-term margin recovery. If sustained, higher gross margins provide structural room to cover SG&A and reduce the scale needed to reach operating profitability.
Operating Cash Flow Turned PositiveThe shift to positive operating cash flow signals improving core cash generation and operational control versus prior years. Sustained OCF reduces reliance on external financing, enabling reinvestment or deleveraging and improving the company's medium-term liquidity profile.
Bears Say
Sharp Revenue ContractionA ~30% revenue decline materially reduces scale benefits and pressures unit economics. Loss of top-line momentum undermines bargaining power with suppliers, increases fixed-cost absorption needs, and makes margin recovery harder absent clear evidence of sustainable sales stabilization.
Persistent Large Net LossesDeep net losses indicate the company cannot yet convert gross profit into net earnings, producing negative returns on equity. Ongoing losses erode capital over time, limit reinvestment capacity, and raise the risk that structural fixes will be required to reach sustained profitability.
Negative Free Cash FlowContinued negative free cash flow means the business still consumes capital after investments and working-capital needs. That persistent cash burn necessitates external funding or asset actions, posing a medium-term risk to liquidity and the ability to execute strategic initiatives if losses continue.
ClouDr Group Limited News
9955 FAQ
What was ClouDr Group Limited’s price range in the past 12 months?
ClouDr Group Limited lowest stock price was HK$0.52 and its highest was HK$1.80 in the past 12 months.
What is ClouDr Group Limited’s market cap?
ClouDr Group Limited’s market cap is HK$437.54M.
When is ClouDr Group Limited’s upcoming earnings report date?
ClouDr Group Limited’s upcoming earnings report date is Aug 14, 2026 which is in 85 days.
How were ClouDr Group Limited’s earnings last quarter?
ClouDr Group Limited released its earnings results on Mar 26, 2026. The company reported -HK$0.636 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.636.
Is ClouDr Group Limited overvalued?
According to Wall Street analysts ClouDr Group Limited’s price is currently Overvalued.
Does ClouDr Group Limited pay dividends?
ClouDr Group Limited does not currently pay dividends.
What is ClouDr Group Limited’s EPS estimate?
ClouDr Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ClouDr Group Limited have?
ClouDr Group Limited has 645,718,800 shares outstanding.
What happened to ClouDr Group Limited’s price movement after its last earnings report?
ClouDr Group Limited reported an EPS of -HK$0.636 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.154%.
Which hedge fund is a major shareholder of ClouDr Group Limited?
Currently, no hedge funds are holding shares in HK:9955
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ClouDr Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-10.34%
12-Months-Change
Fundamentals
Return on Equity
-66.54%
Trailing 12-Months
Asset Growth
-38.03%
Trailing 12-Months
Company Description
ClouDr Group Limited
ClouDr Group Limited, an investment holding company, provides supplies and software as a service (SaaS) to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for chronic condition management. It distributes hospital supplies, which include medical devices, such as blood glucose meters and vital sign monitors, glucose testing strips, and OTC and prescription drugs; and hospital and pharmacy SaaS and digital marketing services to pharmaceutical companies. The company also provides real time consultation, digital condition tracking, and online prescription and ordering services. ClouDr Group Limited was founded in 2014 and is headquartered in Hangzhou, China.
Technical Analysis
China Health Group
―
Sinopharm Group Co
―
IVD Medical Holding Limited
―
Medlive Technology Co., Ltd.
―
Charmacy Pharmaceutical Co., Ltd. Class H
―
Options Prices
Currently, No data available
---